Concordance of MET Amplification between Fluorescence In Situ Hybridization (FISH) and Next-Generation Sequencing (NGS) in Non-Small Cell Lung Carcinoma (NSCLC)

被引:0
|
作者
Ren, Rongqin [1 ]
Shiller, Michelle [2 ]
Chandra, Pranil [1 ]
Crawford, Eric [1 ]
Coldren, Christopher [1 ]
Yin, Lihui [1 ]
机构
[1] Pathgroup, Nashville, TN USA
[2] Pathgroup, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1588
引用
收藏
页码:S1654 / S1654
页数:1
相关论文
共 50 条
  • [31] Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations
    Mehrad, Mitra
    Roy, Somak
    Bittar, Humberto Trejo
    Dacic, Sanja
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (03) : 353 - 357
  • [32] Non-Small Cell Lung Cancer (NSCLC) Next Generation Sequencing (NGS): Integrating Genomic Sequencing into a Publicly Funded Health Care Model
    Perdrizet, K.
    Stockley, T.
    Law, J.
    Shabir, M.
    Zhang, T.
    Le, L.
    Lau, A.
    Tsao, M.
    Kamel-Reid, S.
    Pal, P.
    Cabanero, M.
    Schwock, J.
    Ko, H.
    Liu, G.
    Bradbury, P.
    Sacher, A.
    Shepherd, F.
    Leighl, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S367 - S368
  • [33] Comparison of ALK, RET, and ROS1 Gene Fusion Detection by Next-Generation Sequencing, Fluorescence in situ Hybridization, and Immunohistochemistry in Non-Small Cell Lung Cancer
    Oran, A.
    Grubb, J.
    Lieberman, D. B.
    Sussman, R. T.
    Morrissette, J.
    Rosenbaum, J. N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1033 - 1033
  • [34] Optimal next-generation sequencing (NGS) panel for estimating tumor mutation burden (TMB) and its clinical implication for non-small cell lung cancer (NSCLC).
    Ikeda, Takaya
    Oi, Hajime
    Yoh, Kiyotaka
    Matsumoto, Shingo
    Kato, Terufumi
    Nishino, Kazumi
    Nakamura, Atsushi
    Nakachi, Ichiro
    Sakakibara-Konishi, Jun
    Daga, Haruko
    Furuya, Naoki
    Taima, Kageaki
    Iwama, Eiji
    Ebi, Noriyuki
    Shibata, Yuji
    Izumi, Hiroki
    Nosaki, Kaname
    Zenke, Yoshitaka
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Mutational Screening in KRAS, BRAF, EGFR, C-KIT and PDGFRain Colorectal Carcinoma (CRC) and Non-Small Cell Lung Cancer (NSCLC) Using Next-Generation Sequencing (NGS)
    Hinrichsen, T.
    Wachter, O.
    Dockhorn-Dworniczak, B.
    Klein, H-G
    MODERN PATHOLOGY, 2012, 25 : 513A - 513A
  • [36] Mutational Screening in KRAS, BRAF, EGFR, C-KIT and PDGFRain Colorectal Carcinoma (CRC) and Non-Small Cell Lung Cancer (NSCLC) Using Next-Generation Sequencing (NGS)
    Hinrichsen, T.
    Wachter, O.
    Dockhorn-Dworniczak, B.
    Klein, H-G
    LABORATORY INVESTIGATION, 2012, 92 : 513A - 513A
  • [37] Validation and implementation of next-generation sequencing in liquid biopsies by a novel NGS platform: Focus on non-small cell lung cancer
    Bisgin, Atil
    Sonmezler, Ozge
    Boga, Ibrahim
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Next-Generation Sequencing Implementation in Non-Small Cell Lung Cancer Molecular Diagnosis
    Clave, S.
    Bellosillo, B.
    Salido, M.
    Tagmouti, G.
    Taus, A.
    Rocha, P.
    Hardy-Werbin, M.
    Moliner, L.
    Riera, X.
    Fernandez-Rodriguez, C.
    Arriola, E.
    Pijuan, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S783 - S783
  • [39] Therapeutic strategy for non-small cell lung cancer in the next-generation sequencing era
    Hayashi, Ryuji
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 1 - 2
  • [40] Clinical applications of a next-generation sequencing panel in non-small cell lung cancer
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Dal Bello, M. G.
    Truini, A.
    Coco, S.
    Vanni, I.
    Alama, A.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 86 - 87